This Newport Beach Medtech Company Has a Plan to Clear the Nation's Coming Spike In Discarded Vaccine Needles
As the country prepares for mass COVID-19 vaccinations, OnSite Waste Technologies is expecting a spike in demand.
The Newport Beach-based company's device quickly sterilizes needles and other biomedical waste, a process that can take clinics and nursing homes over a month as they ship off the hazardous materials to one of the country's several dozen incinerators.
Kernel, a bioscience company aiming to make the inner workings of the human brain easy to read, announced Thursday it's raised $53 million in a Series C round led by General Catalyst.
Other investors include Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO Bryan Johnson, who himself has invested $54 million in the company to date.
Kernel founder and CEO Bryan Johnson has invested $54 million in the company.
- Can Kernel Crack the Brain's Secrets? - dot.LA ›
- Kernel Raises $53M in Quest for Brain-Reading Machines - dot.LA ›
- Scientists Making Brain Computers Worry about Ethics, Safety - dot.LA ›